Clinical Trial Update: Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiotherapy with either nimotuzumab or cisplatin concurrently for stage II-III nasopharyngeal carcinoma; status not specified in the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms | Phase 3 | Status: UNKNOWN